case report aspiration glp-1 receptor agonist anesthesia 2023 Managing patients taking glucagon-like peptide-1 American Society of Anesthesiologists Consensus-Based
Description
GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health
95% CI 0.791.39) or 4-point MACE (HR 0.95
Glucagon increases blood glucose levels, particularly during fasting, and facilitates the mobilization of energy reserves.Synthetic agonists like semaglutide and tirzepatide are stable peptides that specifically activate the receptors of these hormones, amplifying their beneficial effects on glycemic control and weight management
FRIDAY, Feb
